Skip to main content

Table 3 Anticoagulants regimen

From: Early hemodynamic performance of the Trifecta™ surgical bioprosthesis aortic valve in Indian patient population: 12 month outcomes of the EVEREST post-market study

Visits

Anticoagulant regimen n (%)

Baseline

81/100 (81%)

Pre-discharge

95/100 (95%)

6 Month

87/96 (91%)

12 Month

79/90 (88%)

  1. n = Total number of patients
Back to article page

Journal of Cardiothoracic Surgery

ISSN: 1749-8090

Contact us